title: Citalopram, a selective serotonin reuptake inhibitor, improves symptoms of Friedreich's ataxia.
abstract: Two patients (siblings) with Friedreich's ataxia showed improvement in their clinical symptoms--particularly spasticity and cardiac symptoms--after treatment with the selective serotonin reuptake inhibitor citalopram.
authors.forename: A
authors.initials: A
authors.lastname: Rohr
authors.forename: K
authors.initials: K
authors.lastname: Eichler
authors.forename: N
authors.initials: N
authors.lastname: Hafezi-Moghadam
mesh_terms: D000328:Adult; D015283:Citalopram / Q000627:therapeutic use*; D005260:Female; D005621:Friedreich Ataxia / Q000188:drug therapy*; D006801:Humans; D008297:Male; D009679:Nuclear Family; D017367:Selective Serotonin Reuptake Inhibitors / Q000627:therapeutic use*; D016896:Treatment Outcome
chemical_list: D015283:Citalopram; D017367:Selective Serotonin Reuptake Inhibitors